Abstract
Blocking inflammation could be a curative approach in pulmonary vascular diseaseshttp://ow.ly/dW5M30hB6aj
Funding Information
  • National Heart, Lung, and Blood Institute (P01HL014985, R01HL135872, R03HL133306)
  • Gilead Sciences (Research Scholars Program in Pulmonary Arterial Hy)
  • American Thoracic Society / Pulmonary Hypertension Association (Research Fellowship)

This publication has 31 references indexed in Scilit: